AS-IV inhibits the progression of ovarian cancer by targeting the circ_0124787/miR-6875–3p/IL-1β axis
Our results describe a novel AS-IV/circ_0124787/miR-6875-3p/IL-1β pathway that can decrease the proportion of γδT17 cell to suppress ovarian cancer.
Authors
- Ziyi Xiao
- Dongwei Zhu (ORCID: https://orcid.org/0000-0002-1487-8573)
- Jinhua Wang (ORCID: https://orcid.org/0000-0001-8367-0787)
- Lihua Zhang (ORCID: https://orcid.org/0000-0003-2543-1547)
- Xiaojian Liu (ORCID: https://orcid.org/0000-0002-8884-4448)
- Na Fu (ORCID: https://orcid.org/0009-0001-1456-817X)
- Siyue Zhang (ORCID: https://orcid.org/0000-0003-2723-9428)
- Jindong Dai
Institutions
- Jiangsu University (CN)
- Jiangsu Cancer Hospital (CN)
Publication Details
- Journal
- Biomedicine & Pharmacotherapy
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1016/j.biopha.2025.118681
- Citations
- 1
- Primary Topic
- Circular RNAs in diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.81